A Double-blind, Placebo-controlled Study of RGH-188 (Cariprazine) in Bipolar Depression
A Double-blind, Placebo-controlled Study of RGH-188 (Cariprazine) in Bipolar Depression
The purpose of this study is to evaluate the efficacy, safety, and tolerability of cariprazine in the treatment of outpatients with bipolar depression.
Inclusion Criteria:
Exclusion Criteria: